These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Neuromyelitis optica and aquaporin-4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland. Siuko M; Tienari PJ; Saastamoinen KP; Atula S; Miettinen A; Kivelä T; Setälä K Acta Ophthalmol; 2014 Jun; 92(4):387-91. PubMed ID: 23773223 [TBL] [Abstract][Full Text] [Related]
25. [Comparison of three anti-aquaporin 4 antibody detection methods in neuromyelitis optical]. Ye J; Liao ZY; Sun H; You XF; Wu XL; Li CJ Zhonghua Nei Ke Za Zhi; 2011 Oct; 50(10):848-50. PubMed ID: 22321326 [TBL] [Abstract][Full Text] [Related]
26. Combined screening for serum anti-nuclear and anti-aquaporin-4 antibodies improves diagnostic accuracy for distinguishing neuromyelitis optica from multiple sclerosis. Wu L; Huang D; Yang Y; Wu W Eur Neurol; 2014; 72(1-2):103-8. PubMed ID: 24993096 [TBL] [Abstract][Full Text] [Related]
27. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Rostásy K; Mader S; Hennes EM; Schanda K; Gredler V; Guenther A; Blaschek A; Korenke C; Pritsch M; Pohl D; Maier O; Kuchukhidze G; Brunner-Krainz M; Berger T; Reindl M Mult Scler; 2013 Jul; 19(8):1052-9. PubMed ID: 23257621 [TBL] [Abstract][Full Text] [Related]
28. Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study. Kovacs KT; Kalluri SR; Boza-Serrano A; Deierborg T; Csepany T; Simo M; Rokusz L; Miseta A; Alcaraz N; Czirjak L; Berki T; Molnar T; Hemmer B; Illes Z Mult Scler; 2016 Aug; 22(9):1192-201. PubMed ID: 26514978 [TBL] [Abstract][Full Text] [Related]
29. [Anti-aquaporin 4 antibody in Japanese multiple sclerosis with long spinal cord lesions]. Tanaka K Rinsho Shinkeigaku; 2007 Nov; 47(11):852-4. PubMed ID: 18210816 [TBL] [Abstract][Full Text] [Related]
30. [Detection of anti-aquaporin 4 antibody in neuromyelitis optical]. Liao ZY; Ye J; Sun H; You XF; Guan YQ Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(13):1012-5. PubMed ID: 23886267 [TBL] [Abstract][Full Text] [Related]
32. Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels. Nakashima I; Takahashi T; Cree BA; Kim HJ; Suzuki C; Genain CP; Vincent T; Fujihara K; Itoyama Y; Bar-Or A J Clin Neurosci; 2011 Jul; 18(7):997-8. PubMed ID: 21565508 [TBL] [Abstract][Full Text] [Related]
33. Relationship between NMO-antibody and anti-MOG antibody in optic neuritis. Kezuka T; Usui Y; Yamakawa N; Matsunaga Y; Matsuda R; Masuda M; Utsumi H; Tanaka K; Goto H J Neuroophthalmol; 2012 Jun; 32(2):107-10. PubMed ID: 22157536 [TBL] [Abstract][Full Text] [Related]
34. Aquaporin-4 autoantibodies cause asymptomatic aquaporin-4 loss and activate astrocytes in mouse. Chan KH; Zhang R; Kwan JS; Guo VY; Ho PW; Ho JW; Chu AC J Neuroimmunol; 2012 Apr; 245(1-2):32-8. PubMed ID: 22394609 [TBL] [Abstract][Full Text] [Related]
35. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827 [TBL] [Abstract][Full Text] [Related]
36. Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Palace J; Leite MI; Nairne A; Vincent A Arch Neurol; 2010 Aug; 67(8):1016-7. PubMed ID: 20697055 [TBL] [Abstract][Full Text] [Related]
37. Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders. Kim SM; Waters P; Woodhall M; Kim JY; Kim JE; Yang JW; Kim JS; Sung JJ; Park KS; Lee KW Mult Scler; 2013 Jul; 19(8):1060-7. PubMed ID: 23329699 [TBL] [Abstract][Full Text] [Related]
38. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Ishii N; Itoyama Y Tohoku J Exp Med; 2006 Dec; 210(4):307-13. PubMed ID: 17146196 [TBL] [Abstract][Full Text] [Related]